Skip to main content
Journal of Palliative Medicine logoLink to Journal of Palliative Medicine
. 2024 Jan 5;27(1):63–74. doi: 10.1089/jpm.2022.0270

Psychometric Properties of the Functional Assessment of Cancer Therapy-General for Evaluating Quality of Life in Patients With Life-Limiting Illness in the Emergency Department

Miryam Yusufov 1,2,, Oluwaseun Adeyemi 3, Mara Flannery 3, Jean-Baptiste Bouillon-Minois 4, Kaitlyn Van Allen 3, Allison M Cuthel 3, Keith S Goldfeld 5, Kei Ouchi 6,7,8, Corita R Grudzen 3,5
PMCID: PMC11074445  PMID: 37672598

Abstract

Background:

The Functional Assessment of Cancer Therapy-General (FACT-G) is a widely used quality-of-life measure. However, no studies have examined the FACT-G among patients with life-limiting illnesses who present to emergency departments (EDs).

Objective:

The goal of this study was to examine the psychometric properties of the FACT-G among patients with life-limiting illnesses who present to EDs in the United States.

Methods:

This cross-sectional study pooled data from 12 EDs between April 2018 and January 2020 (n = 453). Patients enrolled in the study were adults with one or more of the four life-limiting illnesses: advanced cancer, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, or End-Stage Renal Disease. We conducted item, exploratory, and confirmatory analyses (exploratory factor analysis [EFA] and confirmatory factor analysis [CFA]) to determine the psychometric properties of the FACT-G.

Results:

The FACT-G had good internal consistency (Cronbach's alpha α = 0.88). The simplest EFA model was a six-factor structure. The CFA supported the six-factor structure, evidenced by the adequate fit indices (comparative fit index = 0.93, Tucker–Lewis index = 0.92, root-mean-square error of approximation = 0.05; 90% confidence interval: 0.04 – 0.06). The six-factor structure comprised the physical, emotional, work and daily activities-related functional well-being, and the family and friends-related social well-being domains.

Conclusions:

The FACT-G is a reliable measure of health-related quality of life among patients with life-limiting illnesses who present to the ED.

Clinical Trial Registration:

NCT03325985.

Keywords: confirmatory factor analysis, emergency department, exploratory factor analysis, FACT-G, measurement invariance, patients with life-limiting illnesses

Introduction

During the last six months of life, 75% of adults with life-limiting illnesses visit the emergency department (ED).1 Adults with life-limiting illnesses are a heterogeneous group of critically and terminally ill patients, and ED visits are inflection points in these patients' illness trajectories and may signal a more rapid rate of decline.2–4 These patients usually present to the ED with advanced stages of terminal illnesses such as Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD), End-Stage Renal Disease (ESRD), and cancer. More than 70% of these patients express priorities focused on comfort and quality of life rather than life extension.5

Quality of life is an important aspect of palliative care.6 Assessing the quality of life of patients with life-limiting illnesses in the ED may present an opportunity to identify and initiate discussion on hospice and palliative care.7 In addition, palliative care interventions in the ED can capture high-mortality risk patients at a time of crisis.8,9 Palliative care has been shown to decrease depression,10 pain, and anxiety11 and increase patient and caregiver satisfaction.12 Palliative care is also associated with decreased hospital admissions,11 intensive care utilization,13 and overall hospital costs.14 Early initiation of palliative care, therefore, may improve self-reported health-related quality of life (HRQOL) among patients with life-limiting illnesses.

Several measures of HRQOL exist.15–19 However, few HRQOL measures focus on patients with life-limiting illnesses. The Functional Assessment of Cancer Therapy-General (FACT-G), a 27-item survey, is one of the most common measures of HRQOL (see Table 1). Although primarily designed for cancer patients, the FACT-G has been used to assess changes in HRQOL among individuals with chronic illnesses such as nursing home patients,20,21 older adults with Parkinson's disease,22 and women with stress urinary incontinence.23 To our knowledge, no research has validated the FACT-G among adults with life-limiting illnesses who present to the ED. We, therefore, aim to validate the FACT-G and examine its psychometric properties (i.e., item analysis, reliability, exploratory and confirmatory factor analyses) among patients with life-limiting illnesses presenting to the ED.

Table 1.

Psychometric Properties in Prior Studies Using the Functional Assessment of Cancer Therapy-General

Study author and year Country Language Study sample Full scale Cronbach's alpha (α) Number of factors Subscale Cronbach's alpha (α)
Winstead-Fry and Schultz (1997)62 United States English 344 rural cancer patients 0.92 5 Range: 0.68–0.90a
Song et al. (2020)63 United States English Caregivers of 747 cancer patients 0.91 (prostate cancer)
0.91 (advanced cancer)
4 PSEF: 0.81, 0.82, 0.83, 0.86
PSEF: 0.83, 0.84, 0.81, 0.84
Serrano et al. (2016)64 Brazil Portuguese 975 cancer patients Not reportedb 4 Range: 0.71–0.82a
Yu et al. (2000)65 China Chinese 1262 cancer patients 0.85 5 PSDEF: 0.75, 0.53, 0.37, 0.65, 0.75
Lee et al. (2004)66 Korea Korean 193 breast cancer patients 0.89 5 PSSEF: 0.82, 0.86, 0.70, 0.78, 0.90
Dapueto et al. (2001)67 Uruguay Spanish 140 cancer patients 0.83 5 PSDEF: 0.79, 0.65, 0.66, 0.60, 0.72
Thomas et al. (2004)68 India Malayalam, English 214 cancer patients 0.80 (Malayalam patients)
0.89 (English patients)
4 PSEF: 0.75, 0.83, 0.77, 0.64
PSEF: 0.89, 0.63, 0.78, 0.84
Mullin et al. (2000)69 South Africa 3 South African languages 167 cancer patients 0.92 (Pedi patients)
0.89 (Tswana patients)
0.82 (Zulu patients)
5 PSDEF: 0.78, 0.60, 0.80, 0.87, 0.92
PSDEF: 0.79, 0.61, 0.92, 0.76, 0.83
PSDEF: 0.64, 0.36, 0.86, 0.77, 0.80
Conroy et al. (2004)70 France French 310 cancer patients 0.89 5 PSDEF: 0.82, 0.69, 0.65, 0.74, 0.80
Fumimoto et al. (2001)71 Japan Japanese 180 lung cancer patients 0.85 5 PSDEF: 0.81, 0.63, 0.63, 0.81, 0.69
Costet et al. (2005)72 France French 493 cancer patients 0.90 4 PSEF: 0.86, 0.77, 0.83, 0.85
Smith et al. (2007)73 United Kingdom English 465 cancer patients Not reportedb 4 Range: 0.72–0.85a
Overcash et al. (2001)74 United States English 112 cancer patients aged 65+ 0.86 5 PSDEF: 0.78, 0.62, 0.65, 0.60, 0.85
Sanchez et al. (2011)75 Colombia Spanish 473 cancer patients 0.89 4 PSEF: 0.85, 0.79, 0.85, 0.73
a

Range of subscale Cronbach's alpha reported otherwise subscales reported with respect to the order of listed subdomains.

b

Total scale internal consistency reliability not reported; range of internal consistency reliabilities for FACT-G subscales.

NR, not reported; PSDEF, physical well-being, social/family well-being, patient relationship with doctor, emotional well-being, and functional well-being; PSEF, physical well-being, social well-being, emotional well-being, and functional well-being; PSSEF, physical well-being, social well-being-family, social well-being-friends, emotional well-being, and functional well-being.

Methods

Study design and sample

This cross-sectional study pooled data of patients enrolled across 12 EDs in the Emergency Medicine Palliative Care Access (EMPallA) trial between April 2018 and January 2020. EMPallA is a multicenter, Patient-Centered Outcomes Research Institute (PCORI)-funded, two-arm randomized control trial (RCT). The RCT was registered on Clinical Trials.gov,24 and approval was obtained from all appropriate institutional review boards. Further details of the EMPallA protocol have been published.25,26 Since the index study used a cross-sectional design, nonrandomized data for patients that were enrolled in the aforementioned period were used for this psychometric analysis.

Patients enrolled in the study were 50 years or older, scheduled for ED discharge or observation status, spoke either English or Spanish, and had one or more of the four qualifying life-limiting conditions: advanced-stage metastatic solid tumor (hereafter referred to as “cancer”), class III or IV CHF, ESRD, or stage III or IV COPD. In addition, enrolled patients had clinic-accepted health insurance, resided in the geographic area of the recruiting participating EDs, and possessed a working telephone. Study respondents were patients with life-limiting illnesses, and the self-administered survey was administered and completed between day zero and five of the ED presentation.

Functional Assessment of Cancer Therapy-General

The 27-item FACT-G has four subscales: physical well-being (PWB) (seven items), social/family well-being (seven items), emotional well-being (EWB) (six items), and functional well-being (seven items), and these subscales assess the quality of life of patients. The FACT-G has a strong internal consistency, with an aggregate internal consistency of 0.88, averaged across 78 published studies.27 Responses across all four subscales are scored on a 5-point Likert scale (0 = not at all; 1 = a little bit; 2 = somewhat; 3 = quite a bit; and 4 = very much). The FACT-G instrument provides an option for respondents to skip the seventh item in the social/family well-being domain (item GS7: “I am satisfied with my sex life”). About a third (n = 148) of the study participants skipped this item and we removed the item from the analysis. Study participants whose response to item GF1 (“I am able to work (include work at home)”) was “not at all” were asked to skip item GF2 (“My work (including work at home) is fulfilling”). A total of 191 study participants skipped item GF2, and we assigned the value of “not at all” to these GF2 responses, consistent with the principles of scoring valid skip responses.28–30

Handling of missing data

We performed multiple imputations for missing values, using the Multivariate Imputation via Chained Equation (MICE) model,31 after establishing that the missing values were not missing completely at random (Little's test not significant).32 Across the 26-item FACT-G, missingness per item ranged from 1 (0.2%) to 29 (6.4%). For the imputations, we ran 100 iterations, generated 100 predicted values for each missing value, and the final value that replaced the missing value was obtained after generating the mean of the predicted values.33,34

Scoring of the FACT-G

Based on the scoring guidelines,35,36 all items in the PWB domain and five of the six items in the EWB domain were reverse scored. We obtained the subscale scores by summing the individual items in each subscale and we obtained the total FACT-G score by adding the scores across each of the four subscales. Higher scores reflect better quality of life.

Sample characteristics, item analysis, and reliability

We computed the frequency distribution of the sociodemographic and health characteristics of the study sample. Our item analysis consisted of four measures: mean, standard deviation (SD), item discrimination, and consistency. Mid-range values of the items' mean and SD are considered ideal.37 Item discrimination assesses the correlation between the item score and the total score of the full scale.38 The range of values is from −1 to +1, and values >0.20 are considered adequate.38,39 The internal consistency of the FACT-G, a measure of reliability, was examined using Cronbach's alpha (α). We calculated Cronbach's α for the full scale and the four subscales. In addition, we calculated Cronbach's α for the subscales of the final factor structure after the confirmatory factor analysis (CFA). Following recommendations,40–42 we considered Cronbach's α of 0.70–0.79 as “acceptable,” 0.80–0.89 as “good,” and equal to or >0.90 as “excellent.” We computed the recalculated α with each item deleted for the four-factor model. The recalculated α was used to justify that excluding an item will not improve the scale's reliability.

Split-half validation

To address the practical limitations of model building, we conducted split-half (i.e., cross) validation analyses. Specifically, because we could not collect new data to evaluate the fit of the model we tested, we used the same data to assess model fit. Cross-validation techniques focused on using half the data set for modeling the data (i.e., “training set” or “derivation sample”) and the other half for testing the performance of the model that was built (i.e., “testing set” or “replication sample”). The sample, therefore, was randomly divided into a derivation sample (n = 227) for the exploratory factor analysis (EFA) and a replication sample (n = 226) for CFA.

Exploratory factor analysis

The factor structure was examined by repeatedly exploring the latent structure using maximum likelihood methods. To identify the simplest factor model (i.e., the model with minimal or no cross-loadings of items on more than one factor) that best fits the observed data, we chose an iterative analytical approach with increasing complexity—from an unrotated model to orthogonal and oblique rotations. The number of possible factors was determined by examining the number of factors that correspond to Eigenvalues >1, the major bend in the scree plot, and more than 50% of the cumulative proportion of the variance of the FACT-G scores.43 The results of unrotated, orthogonal rotated, and oblique rotated solutions were compared. To facilitate model interpretation, we suppressed factor loading coefficients <0.25 from the results.

Confirmatory factor analysis

To determine the reliability of the factor structure that emerged from the EFA, we performed a CFA. Model fit and factor loadings were evaluated. Specifically, we reported comparative fit index (CFI), Tucker–Lewis index (TLI), and root-mean-square error of approximation (RMSEA). CFI and TLI >0.90 are deemed adequate fit, while values >0.95 are deemed a good fit.44,45 RMSEA values <0.05 indicate good fit, values 0.05–0.08 suggest adequate fit, values 0.08–0.10 suggest marginal fit, and values 0.10 and higher indicate poor fit.44–46 Furthermore, we compared the factor structure that emerged from this study with the original four-domain factor structure (hereafter referred to as the “original FACT-G”), and we compared the models using Akaike information criteria (AIC) and Bayesian information criteria (BIC). The lower the AIC and BIC, the better the model. Post hoc model modifications were limited to placing covariance on the item-specific residual variance (represented by item error terms). These modifications were guided by the standardized expected parameter change (SEPC), modification index (MI), and conceptual relationship of the items identified by the SEPC and MI. Item residual was allowed to covary within their latent factor if there was a valid conceptual explanation, the SEPC was a value >0.2, and the MI was greater than the critical value of 3.84.47 To minimize modification, the critical MI value was set to 10.0.

Data analysis

Frequency distribution and missing data analysis were conducted in R version 4.1.0.48,49 Item analysis and EFA were conducted using the IBM Statistical Package for Social Sciences (SPSS) version 27.50 CFA was conducted using IBM SPSS Amos, version 27.51

Results

Sample characteristics

Our sample consisted of 453 adults with life-limiting illnesses. The sample was predominantly aged 50–64 years (42%), female (54%), non-Hispanic White (57%), married (40%), with high school education or less (41%), and a yearly income <$25,000 (42%) (Table 2). With regards to functional status, ∼27% of the sample required occasional assistance with activities of daily living, 27% required considerable assistance, and 6% had a disability. The mean (SD) FACT-G score was 60.8 (18.1). There were no differences in the sociodemographic and health characteristics of the sample pooled into the derivation and replication samples.

Table 2.

Demographic and Health Characteristics Sample of Seriously Ill Adults Enrolled in the Emergency Medicine Palliative Care Access Study (n = 453)

Variables Total population, n (%) Derivation sample, n = 227 (%) Replication sample, n = 226 (%) p
Age categories
 50–64 years 192 (42.4) 96 (42.3) 96 (42.5) 0.277
 65–74 years 153 (33.8) 69 (30.4) 84 (37.2)  
 75–84 years 79 (17.4) 45 (19.8) 34 (15.0)  
 85 years and older 29 (6.4) 17 (7.5) 12 (5.3)  
Sex
 Male 209 (46.1) 110 (48.5) 99 (43.8) 0.321
 Female 244 (53.9) 117 (51.5) 127 (56.2)  
Race/ethnicity
 Non-Hispanic White 257 (56.7) 123 (54.2) 134 (59.3) 0.500
 Non-Hispanic Black 131 (28.9) 70 (30.8) 61 (27.0)  
 Hispanic 17 (3.8) 7 (3.1) 10 (4.4)  
 Other races 48 (10.6) 27 (11.9) 21 (9.3)  
Marital status
 Married 179 (39.5) 93 (41.0) 86 (38.1) 0.468
 Never married 104 (23.0) 49 (21.6) 55 (24.3)  
 Separated/divorced 93 (20.5) 42 (18.5) 51 (22.6)  
 Widow/widower 77 (17.0) 43 (18.9) 34 (15.0)  
Educational attainment
 High school or less 186 (41.1) 93 (41.0) 93 (41.2) 0.114
 Some college 142 (31.3) 69 (30.4) 73 (32.3)  
 Bachelor's degree 76 (16.8) 46 (20.3) 30 (13.3)  
 Graduate degree or higher 49 (10.8) 19 (8.4) 30 (13.3)  
Yearly income categories
 <$25,000 191 (42.2) 97 (42.7) 94 (41.6) 0.533
 $25,000–$49,999 129 (28.5) 60 (26.4) 69 (30.5)  
 $50,000–$99,999 78 (17.2) 38 (16.7) 40 (17.7)  
 $100,000 and higher 55 (12.1) 32 (14.1) 23 (10.2)  
Comorbid illness
 Cancer only 173 (38.2) 93 (41.0) 80 (35.4) 0.128
 CHF only 71 (15.7) 32 (14.1) 39 (17.3)  
 COPD only 85 (18.8) 36 (15.9) 49 (21.7)  
 ESRD only 65 (14.3) 32 (14.1) 33 (14.6)  
 2 or more comorbidity excluding cancer 45 (9.9) 29 (12.8) 16 (7.1)  
 2 or more comorbidity; cancer inclusive 14 (3.1) 5 (2.2) 9 (4.0)  
Population type
 Cancer population 187 (41.3) 98 (43.2) 89 (39.4) 0.413
 Noncancer population 266 (58.7) 129 (56.8) 137 (60.6)  
Functional status
 Normal activity 123 (27.2) 70 (30.8) 53 (23.5)  
 Cares for self 102 (22.5) 47 (20.7) 55 (24.3)  
 Requires occasional assistance 123 (27.1) 59 (26.00) 64 (28.3)  
 Requires considerable assistance 76 (16.8) 35 (15.4) 41 (18.1)  
 Disabled 29 (6.4) 16 (7.0) 13 (5.8)  
FACT-G score, mean (SD)
 Physical Well-Being 15.7 (5.9) 16.1 (5.7) 15.3 (6.2) 0.156
 Social Well-Being 17.2 (5.9) 17.0 (6.1) 17.5 (5.7) 0.330
 Emotional Well-Being 15.4 (5.8) 15.8 (5.9) 15.0 (5.7) 0.131
 Functional Well-Being 12.5 (6.7) 12.7 (6.7) 12.2 (6.6) 0.395
 Total Fact-G Score 60.7 (18.1) 61.6 (18.0) 60.0 (18.2) 0.348

CHF, Congestive Heart Failure; COPD, Chronic Obstructive Pulmonary Disease; ESRD, End-Stage Renal Disease; FACT-G, Functional Assessment of Cancer Therapy-General; SD, standard deviation.

Item analysis and reliability of the original FACT-G factor model

Using the total sample, the mean (SD) of the 26 items in the FACT-G ranged from 1.23 to 3.14 (1.19–1.50) (Table 3). The mean (95% confidence interval [CI]) score for the FACT-G scale was 2.34 (2.16–2.52) with the social (2.87 [2.69–3.05]) and functional well-being subscales (1.78 [1.60–1.96]) having the highest and lowest mean scores, respectively. Item-total correlations ranged from 0.244 to 0.699. The internal consistency (Cronbach's α) for the total FACT-G scale was 0.884 and deleting any of the 26 items would not substantially improve the internal consistency of the scale. Since the item means and SDs were midrange values, the item-total correlations were higher than 0.20, and deleting any item would not improve the scale, all items were retained. The internal consistency for the physical, emotional, functional, and social well-being subscales was 0.72, 0.83, 0.81, and 0.80, respectively.

Table 3.

Functional Assessment of Cancer Therapy-General Item Analysis Using the Full Sample (n = 453) of Seriously Ill Adults Enrolled in the Emergency Medicine Palliative Care Access Study

ID FACT-G question Item code Mean SD Item-total correlation Subscale metrics (n = 453)
GP1 I have a lack of energy Lack of energya 1.66 1.27 0.376 Physical Well-Being
Average Score: 2.24
95% CI: 2.06–2.42
Cronbach's α: 0.715
GP2 I have nausea Nauseaa 3.07 1.19 0.274
GP3 Because of my physical condition, I have trouble meeting the needs of my family Meeting family needsa 2.46 1.49 0.396
GP4 I have pain Paina 1.75 1.44 0.400
GP5 I am bothered by side effects of treatment Side effectsa 2.59 1.46 0.244
GP6 I feel ill Feel illa 1.99 1.41 0.545
GP7 I am forced to spend time in bed Time in beda 2.18 1.48 0.388
GS1 I feel close to my friends Close friends 2.57 1.45 0.404 Social Well-Being
Average Score: 2.87
95% CI: 2.69–3.05
Cronbach's α: 0.828
GS2 I get emotional support from my family Family support 3.00 1.33 0.440
GS3 I get support from my friends Friend support 2.57 1.42 0.381
GS4 My family has accepted my illness Family accepting illness 3.06 1.24 0.334
GS5 I am satisfied with family communication about my illness Family communication 2.90 1.36 0.408
GS6 I feel close to my partner (or the person who is my main support) Close to partner 3.14 1.30 0.355
GE1 I feel sad Feel sad 2.39 1.31 0.536 Emotional Well-Being
Average Score: 2.56
95% CI: 2.39–2.73
Cronbach's α: 0.814
GE2 I am satisfied with how I am coping with my illness Coping with illness 2.30 1.32 0.559
GE3 I am losing hope in the fight against my illness Fighting illnessa 3.08 1.25 0.500
GE4 I feel nervous Feel nervousa 2.49 1.39 0.511
GE5 I worry about dying Worry about dyinga 2.95 1.35 0.491
GE6 I worry that my condition will get worse Condition worsea 2.15 1.40 0.485
GF1 I am able to work (include work at home) Able to work 1.23 1.31 0.435 Functional Well-Being
Average Score: 1.78
95% CI: 1.60–1.96
Cronbach's α: 0.799
GF2 My work (include work at home) is fulfilling Work fulfilling 1.36 1.50 0.391
GF3 I am able to enjoy life Enjoy life 2.02 1.35 0.699
GF4 I have accepted my illness Accept illness 2.87 1.28 0.360
GF5 I am sleeping well Sleep well 1.73 1.47 0.487
GF6 I am enjoying the things I usually do for fun Fun things 1.58 1.46 0.603
GF7 I am content with the quality of my life right now Quality of life 1.67 1.49 0.627
FACT-G Total Scale Metrics
Average Score: 2.34 95% CI: 2.16–2.52 Cronbach's α: 0.884
a

Item was reverse scored; all questions use a 5-point rating scale: 0 = not at all; 1 = a little bit; 2 = somewhat; 3 = quite a bit; and 4 = very much. Cronbach's alpha would range from 0.875 to 0.885 if any item is deleted, suggesting that reliability would not be substantially changed by deleting any one item. Item GS7 (“I am satisfied with my sex life”) was optional, and the missingness in GS7 was 33%. Item GS7 was excluded. However, when it was added to the analyses (after multiple imputations), Cronbach's alpha on the 27 items was 0.883; adding or removing the item GS7 did not improve or weaken the scale.

Exploratory factor analysis

Across the 26 items in the derivation sample, the cumulative proportion of explained variance >50% corresponded to a four-factor model, the major bend of the scree plot corresponded to a five-factor model, while the number of Eigenvalues >1 corresponded to a seven-factor model. After several iterations of EFA, the simplest model with the least cross-loading was a six-factor model (cumulative proportion = 58.7% of total variance), created through an orthogonal rotation.

Consistent with the original FACT-G, all seven items in the PWB category were loaded on one domain with estimates ranging from 0.30 to 0.66 (Table 4). Two separate domains, social well-being: family (SFM) and social well-being: friends (SFR), emerged from items that measure social well-being. Four items were loaded on SFM with estimates ranging from 0.35 to 0.85. Two items were loaded on SFR, with estimates being 0.79 and 0.87. All items but one (GE2) in the EWB in the original FACT-G were loaded on one domain, with estimates ranging from 0.58 to 0.76. Two separate domains, functional well-being: work (FWW) and functional well-being: daily activities (FWD), emerged from items that measure functional well-being. Two items were loaded on FWW, with estimates ranging from 0.75 to 0.92. All remaining four items in the original FACT-G's functional well-being scale along with an item from the EWB scale (GE2) were loaded on FWD, with estimates ranging from 0.30 to 0.71.

Table 4.

Exploratory Factor Analysis of the 26-Item Functional Assessment of Cancer Therapy-General Scale Showing the Identified Domains Among Seriously Ill Adults Enrolled in the Emergency Medicine Palliative Care Access Study for the Derivation Sample (n = 227)

Items ID PWB SFM SFR EWB FWW FWD
GP1 0.358       .  
GP2 0.503          
GP3 0.299          
GP4 0.419          
GP5 0.405          
GP6 0.659          
GP7 0.547          
GS2   0.682        
GS4   0.802        
GS5   0.852        
GS6   0.347        
GS1     0.789      
GS3     0.870      
GE1       0.575    
GE3       0.566    
GE4       0.717    
GE5       0.759    
GE6       0.687    
GF1         0.922  
GF2         0.753  
GF3           0.705
GF4           0.296
GF5           0.368
GF6           0.614
GF7           0.701
GE2           0.361

Rotation converged in six iterations. Item GS7 was excluded from analyses. Values represent the factor loading coefficients. Factor loading coefficients <0.25 were suppressed for ease of identifying the primary domain of each item. Extraction method was maximum likelihood. Rotation method was varimax with kaiser normalization.

EWB, emotional well-being; FWD, functional well-being: daily activities; FWW, functional well-being: work; PWB, physical well-being; SFM, social well-being: family; SFR, social well-being: friends.

Confirmatory factor analysis

A comparison of the four-factor structure of the original FACT-G domains and the EFA-derived six-factor model (without post hoc modifications) showed that in the replication sample, CFI and TLI values were higher in the six-factor model (Table 5). In addition, the RMSEA, AIC, and BIC values were lower in the six-factor model compared to the four-factor model. After assessing MI and SEPC, the model was modified post hoc by allowing covariations of item residual of two sets of items. The two sets of items are (1) GF4 and GE2 (“I have accepted my illness” vs. “I am satisfied with how I am coping with my illness”) and (2) GS4 and GS5 (“My family has accepted my illness” vs. “I am satisfied with family communication about my illness”). GF4 and GE2 were related conceptually, had high MI (12.4) and SEPC values (0.32), and the correlation coefficient of their item residuals was 0.25. Similarly, GS4 and GS5 were related conceptually, had high MI (15.0) and SEPC values (0.21), and the correlation coefficient of their item residuals was 0.48 (Fig. 1). The modified six-factor structure exhibited good factorial validity with a CFI of 0.93, TLI of 0.92, and RMSEA of 0.049 (90% CI: 0.040–0.058). Across the six domains in the replication sample (n = 226), all the path coefficients were >0.4 (Fig. 1).

Table 5.

Fit Indices for the Functional Assessment of Cancer Therapy-General Confirmatory Models Using the Replication Dataset (n = 226)

Fit index Original FACT-G domains
EFA-based model
Final modified model (with interpretation)
Four-factor structure Six-factor structure Six-factor structure
Comparative fit index 0.832 0.905 0.927 (adequate)
Tucker–Lewis index 0.814 0.891 0.916 (adequate)
RMSEA (90% CI) 0.070 (0.062–0.078) 0.056 (0.047–0.064) 0.049 (0.040–0.058) adequate
AIC 782.44 669.89 625.29 (lower is better)
BIC 805.35 695.26 651.20 (lower is better)
χ2 (df) 614.44 (293) 483.89 (284) 435.29 (282)
PCMIN/DF 2.097 1.704 1.544 (adequate)

Results are based on the replication sample.

χ2 (df), Chi-square (degree of freedom); AIC, Akaike information criteria; BIC, Bayesian information criteria; CI, confidence interval; df, degrees of freedom; EFA, exploratory factor analysis; PCMIN/DF, ratio of Chi-square and the degree of freedom; RMSEA, root-mean-square error of approximation.

FIG. 1.

FIG. 1.

CFA using the replication dataset (n = 226) showing the six-factor correlated model structure for the FACT-G. Rectangles represent FACT-G items, and ovals represent latent variables. Numbers on straight arrows represent standardized path coefficients. Numbers on curved arrows represent the correlation coefficient. Item GS7 was excluded from analyses. CFA, confirmatory factor analysis; e, error; EWB, emotional well-being; FACT-G, Functional Assessment of Cancer Therapy-General; FWD, functional well-being: daily activities; FWW, functional well-being: work; PWB, physical well-being; SFM, social well-being: family; SFR, social well-being: friends.

Supplementary analyses

After confirming the six-factor structure of the FACT-G, we re-estimated Cronbach's α value across the six subscales. The Cronbach's α values for the PWB, SFM, SFR, EWB, FWW, and FWD subscales were 0.715, 0.816, 0.846, 0.816, 0.860, and 0.801, respectively (Supplementary File). Since our sample population represents patients with advanced cancer, CHF, ESRD, and COPD, we reported the results of the item reliability, convergent validity, CFA, and measurement invariance among patients with cancer and noncancer diagnoses (Supplementary File).

Discussion

We assessed the psychometric properties of the FACT-G in a sample of patients with life-limiting illnesses presenting to the ED. The 26-item FACT-G scale had good reliability, and the six-factor structure can be used to assess functional assessment among patients with life-limiting illnesses in the ED. In this study, the segregation of family and friends domains, and the distinction between work and other daily activities, in the social and functional well-being scales, respectively, emerged in the sample of patients with life-limiting illnesses presenting to the ED.

To our knowledge, this study is the only psychometric investigation of the FACT-G in a sample of adults with life-limiting illnesses who present to the ED. Indeed, a number of equally reliable and validated HRQOL questionnaires exist, some of which include Flanagan's Quality of Life Scale,52 McGill Quality of Life Questionnaire,53 and the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire.54 However, the FACT-G scale uniquely provides a measure of assessing the quality of the patient's relationships and support system.55 Using the sufficiently high internal consistency (Cronbach's α) score of the FACT-G scale in our study population, the FACT-G can be considered as a reliable quality of life measure for adults with life-limiting illnesses who present in the ED.

We reported the reliabilities of the subscales in the original four-factor and our reported six-factor models. While the acceptable levels of Cronbach's α of the scales suggest that the instrument can reliably measure the quality of life of patients with life-limiting illnesses, the subscales portray the dimensionality that can be assessed.56,57 The acceptable levels of Cronbach's α across all the other subscales further suggest good construct validity of the scale, good reliability of the subscales, and may provide additional information on which quality of life domains clinicians should address for each patient with life-limiting illnesses.

In contrast to the original four-factor structure, we report a six-factor structure, which may reflect the social and functional characteristics of patients with life-limiting illnesses at the time of presentation to the ED. Specifically, there were two social well-being (family and friends) domains with significantly different mean scores. A possible explanation may be that patients with life-limiting illnesses undergoing an acute event may place greater value on family in end-of-life care, compared to friends. In addition, there were two functional well-being (work and daily activities) domains with significantly different mean scores. This response pattern may suggest that the ability to work will likely be of less importance to adults with life-limiting illnesses experiencing acute events and this may explain why the mean scores of FWW were lower.

Given the widespread use of the FACT-G in both clinical and research settings, the present study offers numerous clinical implications. First, the FACT-G can be used to assess the quality of life among patients with life-limiting illnesses who presented to the ED. It is therefore a useful tool to identify the needs and resources of patients, initiate serious illness conversations, and monitor treatment outcomes and disease progression. Second, patients with life-limiting illnesses may view their social interactions with their family differently compared to social interactions with friends and may perceive their ability to work as a low priority compared to sleep or leisure activities. Indeed, patients' priorities vary widely, and clinicians should seek to understand and address each patient's priorities. Third, we advocate that among patients with life-limiting illnesses who present to the ED, item GS7 (“I am satisfied with my sex life”) can be skipped. Some studies have reported performing mean or multiple imputations for item GS7 that we excluded.58,59 When we imputed the missing values in GS7, the resulting CFA model performed worse compared to the six-factor model, although substantially better than the four-factor 27-item FACT-G. Removing this item only improved our model without producing a change in the two social well-being domains. Furthermore, we advocate introducing a skip statement to item GF2 “My work (include work at home) is fulfilling” if the response to item GF1“I am able to work (include work at home)” is “not at all.” It is unlikely that patients with life-limiting illnesses will interpret “work” differently in items GF1 and GF2. We assessed the sensitivity of our introduction of a skip sequence in GF2 compared to imputing values for missing GF2. The six-factor structure was preserved in both cases, and the fit indices were not meaningfully different. Finally, we advocate that the reverse scoring of the six-factor FACT-G should be consistent with the original four-factor FACT-G, and the subscale scores should be multiplied by the number of items in the subscale divided by the number of items answered.36 The range of scores of the 26-item six-factor FACT-G should, therefore, be 0–104.

This study has its limitations. The FACT-G is a self-reported measure, which cannot exclude self-report bias and social desirability responses.60,61 While the EFA is subject to analytical bias, we mitigated this by establishing a rigorous analytical protocol and using a replication sample to confirm the constructs in the EFA. In addition, our findings may be generalized only to the patients with life-limiting illnesses in the 12 EDs from where the study sample was drawn. Our approach to handling the skipped responses in item GF2 might have added artificial homogeneity, increasing the reliability and factorial validity. Our sample population of patients with life-limiting illnesses consists of patients with cancer and noncancer diagnoses. The possibility exists that self-reported responses may differ across cancer and noncancer populations. We have addressed this limitation by comparing the results of item analysis, factorial validity, and assessing measurement invariance in cancer and noncancer populations (Supplementary File). Our result showed that the psychometric properties in these two groups were similar with subtle differences in the PWB subscale. Despite these limitations, this study provides a reliable tool that may be used to assess the functional status among patients with life-limiting illnesses who presented to the ED. While we provide some modifications to the construct and scoring of the six-factor FACT-G model, future studies may compare the predictive accuracy of the FACIT-Pal, the palliative care-modified FACT-G instrument, and our six-factor FACT-G model.

Conclusion

The FACT-G is a reliable tool for assessing functional status among patients with life-limiting illnesses admitted to the ED. Our validation highlights the different roles of family and friends in the social well-being of patients with life-limiting illnesses. In addition, patients with life-limiting illnesses may perceive their ability to work as a low priority. Given the importance of measuring HRQOL in palliative care, this study presents the FACT-G as a reliable tool that can be administered to patients with life-limiting illnesses who present to the ED.

Supplementary Material

Supplemental data
Suppl_File.docx (1.1MB, docx)

Contributor Information

Collaborators: on behalf of EMPallA Investigators

Authors' Contributions

M.Y.: conceptualization, formal analysis, writing. O.A.: formal analysis, writing. M.F.: data curation. J.-B.B.: review and editing. K.V.A.: review and editing, project administration. A.M.C.: review and editing, project administration. K.S.G.: data curation, formal analysis. K.O.: supervision, writing. C.R.G.: supervision, investigation.

Institutional Review Board Statement

Approved by the New York University Grossman School of Medicine Institutional Review Board.

Informed Consent Statement

Written informed consent was obtained from study participants.

Disclaimer

All statements in this report, including its findings and conclusions, are solely those of the authors and do not necessarily represent the views of the PCORI, its Board of Governors, or the Methodology Committee.

Funding Information

This work was (partially) supported through a PCORI Award (PLC-1609-36306). Research reported in this manuscript is also supported by the National Cancer Institute of the National Institutes of Health under Award Number K08CA259538 awarded to Miryam Yusufov. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author Disclosure Statement

No competing financial interests exist.

Supplementary Material

Supplementary File

References

  • 1. Smith AK, McCarthy E, Weber E, et al. Half of older Americans seen in emergency department in last month of life; most admitted to hospital, and many die there. Health Aff (Millwood) 2012;31(6):1277–1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Wilber ST, Blanda M, Gerson LW, et al. Short-term functional decline and service use in older emergency department patients with blunt injuries. Acad Emerg Med 2010;17(7):679–686. [DOI] [PubMed] [Google Scholar]
  • 3. Deschodt M, Devriendt E, Sabbe M, et al. Characteristics of older adults admitted to the emergency department (ED) and their risk factors for ED readmission based on comprehensive geriatric assessment: A prospective cohort study. BMC Geriatr 2015;15:54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Nagurney JM, Fleischman W, Han L, et al. Emergency department visits without hospitalization are associated with functional decline in older persons. Ann Emerg Med 2017;69(4):426–433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Steinhauser KE, Christakis NA, Clipp EC, et al. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 2000;284(19):2476–2482. [DOI] [PubMed] [Google Scholar]
  • 6. World Health Organization. Palliative Care. Fact Sheets Web site. 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/palliative-care [Last accessed: April 21, 2022].
  • 7. Grudzen CR, Emlet LL, Kuntz J, et al. EM Talk: Communication skills training for emergency medicine patients with serious illness. BMJ Support Palliat Care 2016;6(2):219–224. [DOI] [PubMed] [Google Scholar]
  • 8. Wu FM, Newman JM, Lasher A, et al. Effects of initiating palliative care consultation in the emergency department on inpatient length of stay. J Palliat Med 2013;16(11):1362–1367. [DOI] [PubMed] [Google Scholar]
  • 9. Grudzen CR, Richardson LD, Johnson PN, et al. Emergency department-initiated palliative care in advanced cancer: A randomized clinical trial. JAMA Oncol 2016;2(5):591–598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363(8):733–742. [DOI] [PubMed] [Google Scholar]
  • 11. Higginson IJ, Evans CJ. What is the evidence that palliative care teams improve outcomes for cancer patients and their families? Cancer J 2010;16(5):423–435. [DOI] [PubMed] [Google Scholar]
  • 12. El-Jawahri A, Greer JA, Temel JS. Does palliative care improve outcomes for patients with incurable illness? A review of the evidence. J Support Oncol 2011;9(3):87–94. [DOI] [PubMed] [Google Scholar]
  • 13. Khandelwal N, Kross EK, Engelberg RA, et al. Estimating the effect of palliative care interventions and advance care planning on ICU utilization: A systematic review. Crit Care Med 2015;43(5):1102–1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Morrison RS, Dietrich J, Ladwig S, et al. Palliative care consultation teams cut hospital costs for Medicaid beneficiaries. Health Aff (Millwood) 2011;30(3):454–463. [DOI] [PubMed] [Google Scholar]
  • 15. Health Measures. PROMIS. Northwestern University. 2022. Available from: https://www.healthmeasures.net/explore-measurement-systems/promis [Last accessed April 6, 2022].
  • 16. Centers for Disease Control and Prevention. CDC HRQOL–14 “Healthy Days Measure”. Health-Related Quality of Life (HRQOL) Web site. 2018. Available from: https://www.cdc.gov/hrqol/hrqol14_measure.htm [Last accessed: April 6, 2022].
  • 17. RAND Corporation. RAND 36-Item Health Survey 1.0 Questionnaire Items. RAND Healthcare. 36-Item Short Form Survey Instrument (SF-36) Web site. 2022. Available from: https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/survey-instrument.html [Last accessed: April 6, 2022].
  • 18. Diener E, Emmons RA, Larsen RJ, et al. The satisfaction with life scale. J Pers Assess 1985;49(1):71–75. [DOI] [PubMed] [Google Scholar]
  • 19. Haraldstad K, Wahl A, Andenæs R, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res 2019;28(10):2641–2650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Haugan G. Meaning-in-life in nursing-home patients: A valuable approach for enhancing psychological and physical well-being? J Clin Nurs 2014;23(13–14):1830–1844. [DOI] [PubMed] [Google Scholar]
  • 21. Haugan G, Hanssen B, Moksnes UK. Self-transcendence, nurse-patient interaction and the outcome of multidimensional well-being in cognitively intact nursing home patients. Scand J Caring Sci 2013;27(4):882–893. [DOI] [PubMed] [Google Scholar]
  • 22. Hermanns M, Haas BK, Lisk J. Engaging older adults with Parkinson's disease in physical activity using technology: A feasibility study. Gerontol Geriatr Med 2019;5:2333721419842671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Innerkofler PC, Guenther V, Rehder P, et al. Improvement of quality of life, anxiety and depression after surgery in patients with stress urinary incontinence: Results of a longitudinal short-term follow-up. Health Qual Life Outcomes 2008;6:72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. National Institute of Health. Emergency Medicine Palliative Care Access (EMPallA). ClinicalTrials.gov Web site. 2017. Available from: https://clinicaltrials.gov/ct2/show/NCT03325985 [Last accessed: March 24, 2022].
  • 25. Grudzen CR, Shim DJ, Schmucker AM, et al. Emergency Medicine Palliative Care Access (EMPallA): Protocol for a multicentre randomised controlled trial comparing the effectiveness of specialty outpatient versus nurse-led telephonic palliative care of older adults with advanced illness. BMJ Open 2019;9(1):e025692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Schmucker AM, Flannery M, Cho J, et al. Data from emergency medicine palliative care access (EMPallA): A randomized controlled trial comparing the effectiveness of specialty outpatient versus telephonic palliative care of older adults with advanced illness presenting to the emergency department. BMC Emerg Med 2021;21(1):83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Victorson D, Barocas J, Song J, et al. Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: A reliability generalization. Qual Life Res 2008;17(9):1137–1146. [DOI] [PubMed] [Google Scholar]
  • 28. Office of Management and Budget. Standards and Guidelines for Statistical Surveys. Office of Management and Budget: Washington, DC, USA; 2006. [Google Scholar]
  • 29. Rosen AFG, Moore TM, Calkins ME, et al. Effects of skip-logic on the validity of dimensional clinical scores: A simulation study. Psychopathology 2019;52(6):358–366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Manski CF, Molinari F. Skip sequencing: A decision problem in questionnaire design. Ann Appl Stat 2008;2(1):264–285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Azur MJ, Stuart EA, Frangakis C, et al. Multiple imputation by chained equations: What is it and how does it work? Int J Methods Psychiatr Res 2011;20(1):40–49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Little RJ. A test of missing completely at random for multivariate data with missing values. J Am Stat Assoc 1988;83(404):1198–1202. [Google Scholar]
  • 33. Nassiri V, Lovik A, Molenberghs G, et al. On using multiple imputation for exploratory factor analysis of incomplete data. Behav Res Methods 2018;50(2):501–517. [DOI] [PubMed] [Google Scholar]
  • 34. Dray S, Josse J. Principal component analysis with missing values: A comparative survey of methods. Plant Ecol 2015;216(5):657–667. [Google Scholar]
  • 35. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 1993;11(3):570–579. [DOI] [PubMed] [Google Scholar]
  • 36. Arnold B, Bredle J, Lent L, FACIT Group. FACT-G Scoring Downloads. 2021. Available from: https://www.facit.org/measures-scoring-downloads/fact-g-scoring-downloads [Last accessed: April 6, 2022].
  • 37. McGahee TW, Ball J. How to read and really use an item analysis. Nurse Educ 2009;34(4):166–171. [DOI] [PubMed] [Google Scholar]
  • 38. Salkind NJ (ed.). Item-test correlation. In. Encyclopedia of Research Design. SAGE Publications, Inc.: Thousand Oaks, CA, USA; 2010. [Google Scholar]
  • 39. Metsämuuronen J. Underestimation of the item discrimination power and Somers' D as an alternative for the item-total-and item-rest correlations. Preprint 2019;2:18487..16803. [Google Scholar]
  • 40. Taber KS. The use of Cronbach's alpha when developing and reporting research instruments in science education. Res Sci Educ 2018;48(6):1273–1296. [Google Scholar]
  • 41. Tavakol M, Dennick R. Making sense of Cronbach's alpha. Int J Med Educ 2011;2:53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Knapp TR. Coefficient alpha: Conceptualizations and anomalies. Res Nurs Health 1991;14(6):457–460. [DOI] [PubMed] [Google Scholar]
  • 43. Adeyemi OJ. Mobile phone use while driving: Development and validation of knowledge, attitude, and practice survey instruments. J Saf Res 2021;77:30–39. [DOI] [PubMed] [Google Scholar]
  • 44. Byrne B. Structural Equation Modeling with AMOS: Basic Concepts, Applications, and Programming. Vol 2nd ed. Taylor & Francis Group: New York, NY, USA; 2010. [Google Scholar]
  • 45. Hu Lt, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equ Modeling Multidiscip J 1999;6(1):1–55. [Google Scholar]
  • 46. Fabrigar LR, Wegener DT, MacCallum RC, et al. Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods 1999;4(3):272–299. [Google Scholar]
  • 47. Whittaker TA. Using the modification index and standardized expected parameter change for model modification. J Exp Educ 2012;80(1):26–44. [Google Scholar]
  • 48. R: A Language and Environment for Statistical Computing [Computer Program]. R Foundation for Statistical Computing: Vienna, Austria; 2019. [Google Scholar]
  • 49. van Buuren S, Groothuis-Oudshoorn K. MICE: Multivariate imputation by chained equations in R. J Stat Softw 2011;45(3):1–67. [Google Scholar]
  • 50. IBM Corp. IBM SPSS Statistics for Windows. IBM Corp. 2018. Available from: https://www-01.ibm.com/support/docview.wss?uid=swg21476197 [Last accessed: July 3, 2022].
  • 51. IBM SPSS Amos [Computer Program]. Version 26. IBM SPSS: Chicago, IL, USA; 2016. [Google Scholar]
  • 52. Flanagan JC. Measurement of quality of life: Current state of the art. Arch Phys Med Rehabil 1982;63(2):56–59. [PubMed] [Google Scholar]
  • 53. Cohen SR, Mount BM, Strobel MG, et al. The McGill Quality of Life Questionnaire: A measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med 1995;9(3):207–219. [DOI] [PubMed] [Google Scholar]
  • 54. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85(5):365–376. [DOI] [PubMed] [Google Scholar]
  • 55. Luckett T, King MT, Butow PN, et al. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: Issues, evidence and recommendations. Ann Oncol 2011;22(10):2179–2190. [DOI] [PubMed] [Google Scholar]
  • 56. Gardner PL. Measuring attitudes to science: Unidimensionality and internal consistency revisited. Res Sci Educ 1995;25(3):283–289. [Google Scholar]
  • 57. Iacono T, Tracy J, Keating J, et al. The Interaction with Disabled Persons scale: Revisiting its internal consistency and factor structure, and examining item-level properties. Res Dev Disabil 2009;30(6):1490–1501. [DOI] [PubMed] [Google Scholar]
  • 58. Cheung YB, Daniel R, Ng GY. Response and non-response to a quality-of-life question on sexual life: A case study of the simple mean imputation method. Qual Life Res 2006;15(9):1493–1501. [DOI] [PubMed] [Google Scholar]
  • 59. Fairclough DL, Cella DF. Functional assessment of cancer therapy (FACT-G): Non-response to individual questions. Qual Life Res 1996;5(3):321–329. [DOI] [PubMed] [Google Scholar]
  • 60. Althubaiti A. Information bias in health research: Definition, pitfalls, and adjustment methods. J Multidiscip Healthc 2016;9:211–217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Van de Mortel TF. Faking it: Social desirability response bias in self-report research. Aust J Adv Nurs 2008;25(4):40. [Google Scholar]
  • 62. Winstead-Fry P, Schultz AA. Psychometric analysis of the functional assessment of cancer therapy-general (FACT-G) scale in a rural sample. Cancer 1997;79. [PubMed] [Google Scholar]
  • 63. Song L, Tan X, Bredle J, et al. Psychometric properties of the FACT-G quality of life scale for family caregivers of cancer patients. Qual Life Res 2020;29(8):2241–2252; doi: 10.1007/s11136-020-02477-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Serrano SV, et al. Psychometric characteristics of the Functional Assessment of Cancer Therapy-General when applied to Brazilian cancer patients: A cross-cultural adaptation and validation. Health Qual Life Outcomes 2016;8:14; doi: 10.1186/s12955-015-0400-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Yu CL, Fielding R, Chan CL, et al. Measuring quality of life of Chinese cancer patients: A validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer 2000;88(7):1715–1727. [PubMed] [Google Scholar]
  • 66. Lee EH, Chun M, Kang S, et al. Validation of the Functional Assessment of Cancer Therapy-General (FACT-G) scale for measuring the health-related quality of life in Korean women with breast cancer. Japanese J Clinical Oncol 2004;34(7):393–399; doi: 10.1093/jjco/hyh070 [DOI] [PubMed] [Google Scholar]
  • 67. Dapueto JJ, Francolino C, Gotta I, et al. Evaluation of the Functional Assessment of Cancer Therapy-General Questionnaire (FACT-G) in a South American Spanish speaking population. Psycho-oncology 2001;10(1):88–92; doi: [DOI] [PubMed] [Google Scholar]
  • 68. Thomas B, Pandey M, Ramdas K, et al. FACT-G: Reliability and validity of the Malayalam translation. Qual Life Res 2004;13:263–269; doi: 10.1023/B:QURE.0000015303.68562.3f [DOI] [PubMed] [Google Scholar]
  • 69. Mullin V, Cella D, Chang CH, et al. Development of three African language translations of the FACT-G. Qual Life Res Int J Qual Life Aspects Treat Care and Rehabil 2000;9(2):139–149; doi: 10.1023/a:1008903304950 [DOI] [PubMed] [Google Scholar]
  • 70. Conroy T, Mercier M, Bonneterre J, et al. French version of FACT-G: Validation and comparison with other cancer-specific instruments. European J Cancer 2004;40(15):2243–2252; doi: 10.1016/j.ejca.2004.06.010 [DOI] [PubMed] [Google Scholar]
  • 71. Fumimoto H, Kobayashi K, Chang CH, et al. Cross-cultural validation of an international questionnaire, the General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese. Qual Life Res Int J Qual Life Aspects Treat Care and Rehabil 2001;10(8):701–709; doi: 10.1023/a:1013851216181 [DOI] [PubMed] [Google Scholar]
  • 72. Costet N, Lapierre V, Benhamou E, et al. Reliability and validity of the Functional Assessment of Cancer Therapy General (FACT-G) in French cancer patients. Qual Life Res Int J Qual Life Aspects Treat Care and Rehabil 2005;14(5):1427–1432; doi: 10.1007/s11136-004-5531-z [DOI] [PubMed] [Google Scholar]
  • 73. Smith AB, Wright P, Selby PJ, et al. A Rasch and factor analysis of the Functional Assessment of Cancer Therapy-General (FACT-G). Health Qual Life Outcomes 2007;5:19; doi: 10.1186/1477-7525-5-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Overcash J, Extermann M, Parr J, et al. Validity and reliability of the FACT-G scale for use in the older person with cancer. American J Clin Oncol 2001;24(6):591–596; doi: 10.1097/00000421-200112000-00013 [DOI] [PubMed] [Google Scholar]
  • 75. Sánchez R, Ballesteros M, Arnold BJ. Validation of the FACT-G scale for evaluating quality of life in cancer patients in Colombia. Qual Life Res 2011;20:19–29. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental data
Suppl_File.docx (1.1MB, docx)

Articles from Journal of Palliative Medicine are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES